Stung By COVID Critics, EU Looks To BARDA-Style Agency To Act Faster On Variants
HERA Incubator To Be Launched
Executive Summary
The European Commission wants to learn from mistakes made in the COVID-19 crisis and to create an end-to-end system to co-ordinate funding, clinical research and manufacturing of vaccines.
You may also be interested in...
EU Explains Plans To Speed Up Variant Vaccine Approvals
The EU institutions are taking steps to preserve the effectiveness of existing vaccines in the face of mutations in the SARS-CoV-2 virus.
EU Resets Industry Relations In Pursuit Of Summer COVID-19 Vaccination Goal
The EU has just become the world’s biggest buyer of COVID-19 vaccines – and wants to make that purchasing power count in 2021 and beyond.
EU Launches ‘Structured Dialog’ To Thrash Out Supply Chain Concerns
The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.